Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Hemorrhage 2Urinary Bladder Neoplasms 1Rectal Neoplasms 1Prostatic Neoplasms 1Primary Peritoneal Neoplasm 1Postoperative Complications 1Patients Undergoing Open Resection of Colorectal Tumours 1Neoplasm Metastasis 1Ischemia 1Hearing Loss 1Fluid and Electrolyte Imbalance 1Ear Neoplasms 1Diverticulitis 1Crohn Disease 1Colonic Polyps 1Colonic Neoplasms 1Colitis, Ulcerative 1Blood Loss, Surgical 1

Interventions

pembrolizumab 156Gemcitabine 140Capecitabine 123Paclitaxel 120Fluorouracil 117Oxaliplatin 110Bevacizumab 106Nivolumab 99Leucovorin 97Docetaxel 97Cisplatin 89Radiosurgery 88Irinotecan 87Carboplatin 85Cetuximab 72Cyclophosphamide 71Magnetic Resonance Spectroscopy 68Specimen Handling 60Radiotherapy 60Trastuzumab 59Biopsy 59Ipilimumab 53Drug Therapy 51Everolimus 48Pemetrexed 46Albumin-Bound Paclitaxel 45130-nm albumin-bound paclitaxel 44Doxorubicin 42Fulvestrant 40aldesleukin 37

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasm Metastasis × Ringer's Lactate × Clear all
NCT01242293 2016-02-23

Intrapartum Hydration

HaEmek Medical Center, Israel

Phase NA Completed
300 enrolled
Tumor-Agnostic

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡